• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶及其抑制剂:在哮喘和慢性呼吸道疾病中的新意义。

Histone deacetylases and their inhibitors: new implications for asthma and chronic respiratory conditions.

机构信息

aAllergy and Immune Disorders, Murdoch Children's Research Institute bDepartment of Pathology, The University of Melbourne, Parkville cEpigenomic Medicine, Baker IDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.

出版信息

Curr Opin Allergy Clin Immunol. 2014 Feb;14(1):44-8. doi: 10.1097/ACI.0000000000000029.

DOI:10.1097/ACI.0000000000000029
PMID:24322009
Abstract

PURPOSE OF REVIEW

The importance of the role of histone deacetylase enzymes in the pathogenesis of asthma and chronic respiratory diseases is increasingly being recognized. Similarly, the potential clinical utility of histone deacetylase enzymes in the treatment of disease is emerging. In this review, the role of histone deacetylases (HDAC) and their inhibitors in asthma and chronic obstructive pulmonary disease is discussed.

RECENT FINDINGS

HDAC are able to catalyze the hydrolysis of acetyl groups on lysine residues of histones, causing the condensation and coiling of chromosomal DNA around histones, and therefore regulating gene expression. Histone deacetylase inhibitors act specifically or broadly on HDAC and also on nonhistone targets. Some have been used in the oncology therapeutic field for some years, but it is only more recently that they have been suggested in the treatment of asthma and other inflammatory lung diseases.

SUMMARY

Important developments have been made in the understanding of histone deacetylase expression in normal and diseased airways and pulmonary tissue as well as effects of histone deacetylase inhibitors on structural and inflammatory cells in the lung, including cell proliferation, differentiation and apoptosis and senescence. Many of these discoveries may have implications in addressing airway inflammation, airway remodeling and airway hyperresponsiveness in asthma.

摘要

目的综述

组蛋白去乙酰化酶(HDAC)在哮喘和慢性呼吸系统疾病发病机制中的作用正越来越受到重视。同样,HDAC 酶在疾病治疗中的潜在临床应用也逐渐显现。本文讨论了 HDAC 及其抑制剂在哮喘和慢性阻塞性肺疾病中的作用。

最近的发现

HDAC 能够催化组蛋白赖氨酸残基上乙酰基的水解,导致染色体 DNA 围绕组蛋白凝聚和卷曲,从而调节基因表达。组蛋白去乙酰化酶抑制剂特异性或广泛地作用于 HDAC,也作用于非组蛋白靶点。一些抑制剂已在肿瘤治疗领域使用多年,但直到最近才被提议用于治疗哮喘和其他炎症性肺部疾病。

总结

在正常和患病气道以及肺组织中 HDAC 表达的理解,以及 HDAC 抑制剂对肺内结构细胞和炎性细胞的作用方面取得了重要进展,包括细胞增殖、分化和凋亡以及衰老。这些发现中的许多可能对解决哮喘中的气道炎症、气道重塑和气道高反应性具有重要意义。

相似文献

1
Histone deacetylases and their inhibitors: new implications for asthma and chronic respiratory conditions.组蛋白去乙酰化酶及其抑制剂:在哮喘和慢性呼吸道疾病中的新意义。
Curr Opin Allergy Clin Immunol. 2014 Feb;14(1):44-8. doi: 10.1097/ACI.0000000000000029.
2
Epigenetic regulation of airway inflammation.气道炎症的表观遗传调控
Curr Opin Immunol. 2007 Dec;19(6):694-700. doi: 10.1016/j.coi.2007.07.016. Epub 2007 Aug 27.
3
Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice.组蛋白去乙酰化酶抑制剂曲古抑菌素 A 在小鼠慢性变应性气道疾病模型中的作用。
Arch Immunol Ther Exp (Warsz). 2012 Aug;60(4):295-306. doi: 10.1007/s00005-012-0180-3. Epub 2012 Jun 9.
4
Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?组蛋白与肺癌:组蛋白去乙酰化酶是否为有前途的治疗靶点?
Cancer Chemother Pharmacol. 2013 Nov;72(5):935-52. doi: 10.1007/s00280-013-2223-9. Epub 2013 Sep 14.
5
Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease.丙戊酸对变应性气道疾病小鼠模型气道高反应性和气道重塑的保护作用。
Epigenetics. 2011 Dec;6(12):1463-70. doi: 10.4161/epi.6.12.18396.
6
Targeting transcription factor lysine acetylation in inflammatory airway diseases.靶向炎症性气道疾病中的转录因子赖氨酸乙酰化
Epigenomics. 2017 Jul;9(7):1013-1028. doi: 10.2217/epi-2017-0027. Epub 2017 Jun 15.
7
Histone deacetylase inhibitors: can we consider potent anti-neoplastic agents for the treatment of asthma?组蛋白去乙酰化酶抑制剂:我们能否将其视为治疗哮喘的强效抗肿瘤药物?
Ann Clin Lab Sci. 2012 Summer;42(3):338-45.
8
Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?以类风湿性关节炎和哮喘作为炎症性疾病的典型病例,靶向组蛋白去乙酰化酶活性:我们应该继续保留组蛋白乙酰转移酶吗?
Arthritis Res Ther. 2008;10(5):226. doi: 10.1186/ar2489. Epub 2008 Oct 17.
9
Histone deacetylases and their role in asthma.组蛋白去乙酰化酶及其在哮喘中的作用。
J Asthma. 2012 Mar;49(2):121-8. doi: 10.3109/02770903.2011.648298. Epub 2012 Jan 10.
10
Histone acetylation and deacetylation: importance in inflammatory lung diseases.组蛋白乙酰化与去乙酰化:在炎症性肺部疾病中的重要性
Eur Respir J. 2005 Mar;25(3):552-63. doi: 10.1183/09031936.05.00117504.

引用本文的文献

1
COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks.COVID-19 是一种多器官侵害者:表观遗传和临床标志。
Front Immunol. 2021 Oct 8;12:752380. doi: 10.3389/fimmu.2021.752380. eCollection 2021.
2
Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.有前景的药物再利用方法针对与 SARS-CoV-2 并发症相关的细胞因子风暴。
Immunopharmacol Immunotoxicol. 2021 Aug;43(4):395-409. doi: 10.1080/08923973.2021.1931302. Epub 2021 May 31.
3
Simple Fluorogenic Cellular Assay for Histone Deacetylase Inhibitors Based on Split-Yellow Fluorescent Protein and Intrabodies.
基于分裂型黄色荧光蛋白和细胞内抗体的组蛋白去乙酰化酶抑制剂简单荧光细胞检测法。
ACS Omega. 2021 Apr 7;6(15):10039-10046. doi: 10.1021/acsomega.0c06281. eCollection 2021 Apr 20.
4
Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis.用于治疗肺纤维化的上皮-间质转化表观遗传学修饰的纳米方法
Front Pharmacol. 2020 Dec 11;11:607689. doi: 10.3389/fphar.2020.607689. eCollection 2020.
5
The Role of Epigenetics in the Chronic Sinusitis with Nasal Polyp.表观遗传学在慢性鼻窦炎伴鼻息肉中的作用。
Curr Allergy Asthma Rep. 2020 Nov 24;21(1):1. doi: 10.1007/s11882-020-00976-8.
6
Histone deacetylase 3 controls lung alveolar macrophage development and homeostasis.组蛋白去乙酰化酶 3 控制肺肺泡巨噬细胞的发育和稳态。
Nat Commun. 2020 Jul 30;11(1):3822. doi: 10.1038/s41467-020-17630-6.
7
Recent findings in the genetics and epigenetics of asthma and allergy.哮喘和过敏的遗传学和表观遗传学的最新发现。
Semin Immunopathol. 2020 Feb;42(1):43-60. doi: 10.1007/s00281-019-00777-w. Epub 2020 Feb 14.
8
Omics for the future in asthma.哮喘领域未来的组学研究
Semin Immunopathol. 2020 Feb;42(1):111-126. doi: 10.1007/s00281-019-00776-x. Epub 2020 Jan 15.
9
The role of cigarette smoke-induced epigenetic alterations in inflammation.香烟烟雾引起的表观遗传改变在炎症中的作用。
Epigenetics Chromatin. 2019 Nov 11;12(1):65. doi: 10.1186/s13072-019-0311-8.
10
The crosstalk between microbiome and asthma: Exploring associations and challenges.肠道菌群与哮喘的相互作用:探索关联与挑战。
Clin Exp Allergy. 2019 Aug;49(8):1067-1086. doi: 10.1111/cea.13444. Epub 2019 Jun 27.